These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 29461909)

  • 1. Moderate influenza vaccine effectiveness against influenza A(H1N1)pdm09 virus and low effectiveness against A(H3N2) virus among older adults during 2013-2014 influenza season in Beijing, China.
    Zhang L; Pan Y; Ma C; Duan W; Sun Y; Wu S; Zhang M; Tian Y; Zheng Y; Yang P; Wang Q
    Hum Vaccin Immunother; 2018 Jun; 14(6):1323-1330. PubMed ID: 29461909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season.
    Wu S; Pan Y; Zhang X; Zhang L; Duan W; Ma C; Zhang Y; Zhang M; Sun Y; Yang P; Wang Q; Ma J
    Vaccine; 2018 Sep; 36(38):5774-5780. PubMed ID: 30087046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
    Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F;
    Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza vaccine effectiveness against medically attended influenza illness in Beijing, China, 2014/15 season.
    Ma C; Pan Y; Zhang L; Zhang Y; Wu S; Sun Y; Duan W; Zhang M; Wang Q; Yang P
    Hum Vaccin Immunother; 2017 Oct; 13(10):2379-2384. PubMed ID: 28846480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
    Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
    J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China.
    Yang P; Thompson MG; Ma C; Shi W; Wu S; Zhang D; Wang Q
    Vaccine; 2014 Sep; 32(41):5285-9. PubMed ID: 25092635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.
    Puig-Barberà J; Guglieri-López B; Tortajada-Girbés M; López-Labrador FX; Carballido-Fernández M; Mollar-Maseres J; Schwarz-Chavarri G; Baselga-Moreno V; Mira-Iglesias A; Díez-Domingo J;
    Vaccine; 2017 Dec; 35(52):7331-7338. PubMed ID: 29128380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.
    Kissling E; Valenciano M; Buchholz U; Larrauri A; Cohen JM; Nunes B; Rogalska J; Pitigoi D; Paradowska-Stankiewicz I; Reuss A; Jiménez-Jorge S; Daviaud I; Guiomar R; O'Donnell J; Necula G; Głuchowska M; Moren A
    Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 2015-2016 influenza epidemic in Beijing, China: Unlike elsewhere, circulation of influenza A(H3N2) with moderate vaccine effectiveness.
    Zhang L; Pan Y; Hackert V; van der Hoek W; Meijer A; Krafft T; Yang P; Wang Q
    Vaccine; 2018 Aug; 36(33):4993-5001. PubMed ID: 30017144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children.
    Kissling E; Valenciano M; Pozo F; Vilcu AM; Reuss A; Rizzo C; Larrauri A; Horváth JK; Brytting M; Domegan L; Korczyńska M; Meijer A; Machado A; Ivanciuc A; Višekruna Vučina V; van der Werf S; Schweiger B; Bella A; Gherasim A; Ferenczi A; Zakikhany K; O Donnell J; Paradowska-Stankiewicz I; Dijkstra F; Guiomar R; Lazar M; Kurečić Filipović S; Johansen K; Moren A;
    Influenza Other Respir Viruses; 2018 Jul; 12(4):423-437. PubMed ID: 29125681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations - Latin America, 2013.
    El Omeiri N; Azziz-Baumgartner E; Thompson MG; ; Clará W; Cerpa M; Palekar R; Mirza S; Ropero-Álvarez AM
    Vaccine; 2018 Jun; 36(24):3555-3566. PubMed ID: 28648543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of influenza vaccine in preventing medically-attended influenza virus infection in primary care, Israel, influenza seasons 2014/15 and 2015/16.
    Yaron-Yakoby H; Sefty H; Pando R; Dichtiar R; Katz MA; Stein Y; Mandelboim M; Mendelson E; Shohat T; Glatman-Freedman A;
    Euro Surveill; 2018 Feb; 23(7):. PubMed ID: 29471622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y
    J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of the Effectiveness of Quadrivalent Influenza Vaccines by Distinguishing Between Influenza A (H1N1) pdm09 and Influenza A (H3N2) Using Rapid Influenza Diagnostic Tests During the 2018-2019 Season.
    Ando S
    Intern Med; 2020 Apr; 59(7):933-940. PubMed ID: 31787695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderate influenza vaccine effectiveness against A(H1N1)pdm09 virus, and low effectiveness against A(H3N2) subtype, 2018/19 season in Italy.
    Bellino S; Bella A; Puzelli S; Di Martino A; Facchini M; Punzo O; Pezzotti P; Castrucci MR; The InfluNet Study Group
    Expert Rev Vaccines; 2019 Nov; 18(11):1201-1209. PubMed ID: 31674847
    [No Abstract]   [Full Text] [Related]  

  • 17. Influenza vaccine effectiveness estimates against influenza A(H3N2) and A(H1N1) pdm09 among children during school-based outbreaks in the 2016-2017 season in Beijing, China.
    Zhang L; van der Hoek W; Krafft T; Pilot E; Asten LV; Lin G; Wu S; Duan W; Yang P; Wang Q
    Hum Vaccin Immunother; 2020 Apr; 16(4):816-822. PubMed ID: 31596661
    [No Abstract]   [Full Text] [Related]  

  • 18. Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022.
    Chung JR; Kim SS; Kondor RJ; Smith C; Budd AP; Tartof SY; Florea A; Talbot HK; Grijalva CG; Wernli KJ; Phillips CH; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Reis M; Geffel KM; Nowalk MP; DaSilva J; Keong LM; Stark TJ; Barnes JR; Wentworth DE; Brammer L; Burns E; Fry AM; Patel MM; Flannery B
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(10):365-370. PubMed ID: 35271561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada.
    Andrew MK; Shinde V; Hatchette T; Ambrose A; Boivin G; Bowie W; Chit A; Dos Santos G; ElSherif M; Green K; Haguinet F; Halperin SA; Ibarguchi B; Johnstone J; Katz K; Langley JM; LeBlanc J; Loeb M; MacKinnon-Cameron D; McCarthy A; McElhaney J; McGeer A; Nichols MK; Powis J; Richardson D; Semret M; Stiver G; Trottier S; Valiquette L; Webster D; Ye L; McNeil SA;
    BMC Infect Dis; 2017 Dec; 17(1):805. PubMed ID: 29284435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza vaccine effectiveness in older adults compared with younger adults over five seasons.
    Russell K; Chung JR; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Murthy K; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Flannery B
    Vaccine; 2018 Feb; 36(10):1272-1278. PubMed ID: 29402578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.